Extremely Locally Advanced Ovarian Malignant Mixed Mullerian Tumor in 37-Years-Old Female

1. Harris MA, Delap LM, Sengupta PS et al. Carcinosarcoma of the ovary. Br J Cancer 2003;88(5):654-65710.1038/sj.bjc.6600770Search in Google Scholar

2. Muller M, Dupre PF, Lucas B et al. Carcinosarcoma of the ovary. Journal de gynecologie, obstetrique et biologie de la reproduction. 2007; 36(4):399-40210.1016/j.jgyn.2007.03.001Search in Google Scholar

3. Brown E, Stewart M, Rye T et al. Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer. 2004; 100:2148-5310.1002/cncr.20256Search in Google Scholar

4. Garg G, Shah JP, Kumar S et al. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer. 2010;20:888-89410.1111/IGC.0b013e3181dc8292Search in Google Scholar

5. Petru E, Haas J, Beganovic S et al. Carcinosarcoma (Malignant Mixed Mullerian Tumour) of the ovary- a single institution experience of 25 years. Int J Gynecol Clin Pract. 2015;2:10710.15344/2394-4986/2015/107Search in Google Scholar

6. Reed N, Millan D, Verheijen R et al. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow- up. Ann Oncol. 2010; 21(suppl 5):31-3610.1093/annonc/mdq205Search in Google Scholar

7. Doo DW, Erickson BK, Arend RC et al. Radical surgical cytoreduction in the treatment of ovarian carcinosarcoma. J Am Coll Surgeons. 2014; 133(2):234-710.1016/j.ygyno.2014.03.002Search in Google Scholar

8. Sood A, Sorosky JI, Gelder MS et al. Analysis of prognostic variables and the role of surgical cytoreduction. Cancer- Am Cancer Soc. 1998; 82(9):1731-1737Search in Google Scholar

9. Bacalbasa N, Balescu I, Dima S et al. Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case-control matched study. Anticancer research. 2014; 34:7303-8Search in Google Scholar

10. Barakat RR, Rubin SC, Wong G et al. Mixed mesodermal tumour of the ovary: analysis of prognostic factors in 31 cases. Obstet Gynecol. 1992;80(4):660-4Search in Google Scholar

11. Muntz HG, Jones MA, Goff BA et al. malignant mixed mullerian tumours of the ovary: experiences with surgical cytoreduction and combination chemotherapy. Cancer. 1995;76(7):1209-121310.1002/1097-0142(19951001)76:7<1209::AID-CNCR2820760717>3.0.CO;2-VSearch in Google Scholar

12. McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinoma? J Clin pathol 2002; 55(5):321-325Search in Google Scholar

13. Barnholtz-Sloan JS, Morris R, Malone JM et al. Survival of women diagnosed with malignant, mixed mullerian tumours of the ovary (OMMMT). Gynecol Oncol. 2004; 93(2):506-51210.1016/j.ygyno.2004.02.016Search in Google Scholar